Jhesua Valencia

Dr. Jhesua Valencia


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
JVJhesua Valencia
Jhesua Valencia
VRVivian Rubio
Vivian Rubio
GPGloria Mercedes Puerto
Gloria Mercedes Puerto
LVLuisa Vasquez
Luisa Vasquez
ABAnthony Bernal
Anthony Bernal
DIDaniel Insuasty
Daniel Insuasty
In this study, a series of novel quinolinone-based thiosemicarbazones were designed in silico and their activities tested in vitro against Mycobacterium tuberculosis (M. tuberculosis). Quantitative structure-activity relationship (QSAR) studies were performed using quinolinone and thiosemicarbazide as pharmacophoric nuclei; the best model showed statistical parameters of R2 = 0.83; F = 47.96; s = 0.31, and was validated by several different methods. The van der Waals volume, electron density, and electronegativity model results suggested a pivotal role in antituberculosis (anti-TB) activity. Subsequently, from this model a new series of quinolinone-thiosemicarbazone 11a–e was designed and docked against two tuberculosis protein targets: enoyl-acyl carrier protein reductase (InhA) and decaprenylphosphoryl-β-D-ribose-2’-oxidase (DprE1). Molecular dynamics simulation over 200 ns showed a binding energy of −71.3 to −12.7 Kcal/mol, suggesting likely inhibition. In vitro antimycobacterial activity of quinolinone-thiosemicarbazone for 11a–e was evaluated against M. bovis, M. tuberculosis H37Rv, and six different strains of drug-resistant M. tuberculosis. All compounds exhibited good to excellent activity against all the families of M. tuberculosis. Several of the here synthesized compounds were more effective than the standard drugs (isoniazid, oxafloxacin), 11d and 11e being the most active products. The results suggest that these compounds may contribute as lead compounds in the research of new potential antimycobacterial agents.

30 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
JVJhesua Valencia
Jhesua Valencia
OSOriel Alfredo Sanchez-Velasco
Oriel Alfredo Sanchez-Velasco
JSJorge Saavedra-Olavarría
Jorge Saavedra-Olavarría
PHPatricio Hermosilla-Ibáñez
Patricio Hermosilla-Ibáñez
EPEdwin Perez
Edwin Perez
DIDaniel Insuasty
Daniel Insuasty
3-formyl-2-quinolones have attracted the scientific community’s attention because they are used as versatile building blocks in the synthesis of more complex compounds showing different and attractive biological activities. Using copper-catalyzed Chan–Lam coupling, we synthesized 32 new N-aryl-3-formyl-2-quinolone derivatives at 80 °C, in air and using inexpensive phenylboronic acids as arylating agents. 3-formyl-2-quinolones and substituted 3-formyl-2-quinolones can act as substrates, and among the products, the p-methyl derivative 9a was used as a substrate to obtain different derivatives such as alcohol, amine, nitrile, and chalcone.